Montana's New 'Right to Try' Law Offers Hope for Patients with Rare Diseases
Montana has enacted a new "right to try" law, offering a potential lifeline to patients with rare and terminal illnesses who have exhausted conventional treatment options. Kris DeVault, a father whose son Brody began showing signs of developmental delay and missed key milestones in speech, movement, and coordination shortly after his birth in March 2023, exemplifies the urgency driving such legislation. Brody was diagnosed with a rare genetic condition around the age of two and a half, prompting his father's desperate search for advanced therapies. The "right to try" laws generally allow eligible patients to access experimental drugs that have completed early-stage clinical trials but have not yet received full FDA approval. Proponents argue these laws provide crucial access to potentially life-saving treatments, while critics raise concerns about patient safety and the ethical implications of using unproven therapies. The passage of this law in Montana aims to address the critical need for expanded treatment options for individuals facing devastating diagnoses.
The enactment of Montana's "right to try" law reflects a growing societal tension between the established regulatory pathways for drug approval and the urgent desire for access to potentially life-saving experimental treatments. This legislation attempts to balance patient autonomy and the pursuit of novel therapies against the inherent risks associated with unproven medical interventions. As the pharmaceutical industry increasingly focuses on personalized medicine and treatments for rare diseases, such laws may become more prevalent, prompting a re-evaluation of traditional drug development and approval timelines. The long-term impact will likely depend on robust patient safeguards, clear eligibility criteria, and ongoing dialogue between patient advocacy groups, regulatory bodies, and the medical community to ensure both access and safety are prioritized.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.